Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion type Assertion NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_head.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion description "[We hypothesized that mBC-CML would be resistant to some of the killing mechanisms sufficient to eliminate mCP-CML, but we found instead that the same mechanisms were effective against both types of leukemia, because GVL was similar against wild-type or mBC-CML genetically lacking Fas, TRAIL-R, Fas/TRAIL-R, or TNFR1/R2 or when donor T cells were perforin(-/-).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_provenance.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion evidence source_evidence_literature NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_provenance.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion SIO_000772 21768400 NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_provenance.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion wasDerivedFrom befree-20140225 NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_provenance.
- NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_assertion wasGeneratedBy ECO_0000203 NP820251.RAvmHd0LvcWQr1fTh6kFm8Ap5l1s6-CULGpk1i8-hEup4130_provenance.